PHR3380

Zanamivir

certified reference material, pharmaceutical secondary standard

• 同義詞: Zanamivir, 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid, 4-Guanidino-Neu5Ac2en
• 經驗公式（希爾表示法）: C₁₂H₂₀N₄O₇
• CAS號碼: 139110-80-8
• 分子量：: 332.31
• MDL號碼: MFCD00866966
• 分類程式碼代碼: 41116107

屬性

• 等級: certified reference material; pharmaceutical secondary standard
• 品質等級: 300
• CofA: current certificate can be downloaded
• 包裝: pkg of 500 mg
• 應用: pharmaceutical
• 儲存溫度: 2-30°C
• SMILES 字串: CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
• InChI: 1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
• InChI 密鑰: ARAIBEBZBOPLMB-UFGQHTETSA-N

描述

一般說明

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

生化／生理作用

Zanamivir is an influenza viral neuraminidase inhibitor.

分析報告

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302,H315,H319,H335
• 防範說明: P261 - P264 - P271 - P301 + P312 - P302 + P352 - P305 + P351 + P338
• 危險分類: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 標靶器官: Respiratory system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable